Log in to save to my catalogue

Cefepime-induced neurotoxicity: a systematic review

Cefepime-induced neurotoxicity: a systematic review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1a0ab4bb98ce410f8b0cf8f08dcde4f6

Cefepime-induced neurotoxicity: a systematic review

About this item

Full title

Cefepime-induced neurotoxicity: a systematic review

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2017-11, Vol.21 (1), p.276-276, Article 276

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cefepime is a widely used antibiotic with neurotoxicity attributed to its ability to cross the blood-brain barrier and exhibit concentration-dependent ϒ-aminobutyric acid (GABA) antagonism. Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that up to 15% of ICU patients treated...

Alternative Titles

Full title

Cefepime-induced neurotoxicity: a systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1a0ab4bb98ce410f8b0cf8f08dcde4f6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1a0ab4bb98ce410f8b0cf8f08dcde4f6

Other Identifiers

ISSN

1364-8535

E-ISSN

1466-609X,1364-8535,1366-609X

DOI

10.1186/s13054-017-1856-1

How to access this item